PetIQ (NASDAQ:PETQ) – Stock analysts at Jefferies Group issued their Q1 2018 EPS estimates for shares of PetIQ in a note issued to investors on Tuesday, March 13th, according to Zacks Investment Research. Jefferies Group analyst K. Grundy expects that the company will earn $0.29 per share for the quarter. Jefferies Group currently has a “Buy” rating and a $27.00 target price on the stock. Jefferies Group also issued estimates for PetIQ’s FY2018 earnings at $0.95 EPS and FY2019 earnings at $1.20 EPS.
Other analysts also recently issued reports about the company. Zacks Investment Research raised PetIQ from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research report on Tuesday, January 9th. BidaskClub upgraded PetIQ from a “hold” rating to a “buy” rating in a report on Tuesday, January 23rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. PetIQ presently has an average rating of “Buy” and a consensus price target of $27.50.
Shares of NASDAQ:PETQ traded down $0.87 during midday trading on Friday, reaching $23.23. 430,153 shares of the company’s stock were exchanged, compared to its average volume of 566,356. The company has a current ratio of 5.99, a quick ratio of 3.56 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $564.86 and a price-to-earnings ratio of 59.56. PetIQ has a fifty-two week low of $17.03 and a fifty-two week high of $28.23.
Institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. purchased a new position in shares of PetIQ in the 3rd quarter valued at about $520,000. Eagle Asset Management Inc. purchased a new position in shares of PetIQ in the 4th quarter valued at about $2,020,000. Fred Alger Management Inc. boosted its stake in shares of PetIQ by 544.6% in the 4th quarter. Fred Alger Management Inc. now owns 112,302 shares of the company’s stock valued at $2,453,000 after buying an additional 94,880 shares during the period. EAM Investors LLC purchased a new position in shares of PetIQ in the 3rd quarter valued at about $2,615,000. Finally, Eos Management L.P. purchased a new position in shares of PetIQ in the 3rd quarter valued at about $143,836,000. Institutional investors and hedge funds own 37.02% of the company’s stock.
In related news, CEO Mccord Christensen sold 20,000 shares of the firm’s stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $26.22, for a total transaction of $524,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John Newland sold 5,500 shares of the firm’s stock in a transaction dated Monday, March 19th. The shares were sold at an average price of $24.83, for a total value of $136,565.00. The disclosure for this sale can be found here. Insiders have sold a total of 65,500 shares of company stock valued at $1,657,765 over the last 90 days.
TRADEMARK VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/07/petiq-inc-petq-forecasted-to-earn-q1-2018-earnings-of-0-29-per-share.html.
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Get a free copy of the Zacks research report on PetIQ (PETQ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.